ABIVAX Société Anonyme (EPA:ABVX)
98.40
-2.20 (-2.19%)
Apr 21, 2026, 3:44 PM CET
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
69
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€66,232
Profits / Employee
€4,871,043
Market Cap
7.97B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 69 | 0 | - | 69 | 0 |
| Dec 31, 2024 | 69 | 8 | 13.11% | 69 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | 24 | -3 | -11.11% | 24 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| Innate Pharma | 174 |
| MedinCell | 145 |
| Transgene | 145 |
| DBV Technologies | 117 |
| Nanobiotix | 103 |
ABIVAX Société Anonyme News
- 17 hours ago - Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents - GlobeNewsWire
- 13 days ago - This Beaten-Down Drug Stock Is Down Over 10% -- Is It Finally a Buy? - The Motley Fool
- 19 days ago - Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies - GlobeNewsWire
- 25 days ago - 2 Healthcare Stocks That Could Soar Over the Next 5 Years - The Motley Fool
- 27 days ago - Abivax (ABVX) Shares Drop Amid Financials and Strategic Delays - GuruFocus
- 27 days ago - Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears - Benzinga
- 27 days ago - Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC - CNBC
- 4 weeks ago - 2 Healthcare Stocks to Buy Before They Get Bought Out - The Motley Fool